Success Stories

ValueDo has a long history of helping clients and companies succeed with setting up organizations and capabilities, new launches, updating operating models, engaging with patients, HCPs and payers in novel ways, managing product life cycles, and achieving business excellence. Here are some of our client success stories.


Operating Model Redesign - EU Affiliate Commercial Model

ValueDo supported a Country Head at a top 20 pharma’s EU affiliate with the redesign of the organization’s commercial operating model, go-to-market approach and their internal organization design.

We helped transform from brand-centric to customer-centric operating model, and improved the customer engagement framework, organizational design, ways-of-working and accountability for both HQ and field-facing roles.

Value Delivered:

Focus on customer-centricity and clear understanding of customer preferences

New customer engagement model with clearer HQ and field accountability

Improved organizational design, identification of new roles and clearer focus of current roles to deliver against new performance-based approach

Foundation for a culture of shared vision and co-creation

Expansion Into New Business Segment - Biosimilars

ValueDo supported the Global Head of biosimilars and his team at a top 20 global pharma organization to first set up the this new business segment – biosimilars, and then assisted the team over 4 years with multiple initiatives: business strategy, 2 US brand launches, CEO-led growth initiative, launch excellence across US, Canada, EU and international markets, and other operational exercises.

Value Delivered:

Clear roadmap and business and cross-functional strategy for new biosimilars business

Successful launch of first brand followed by launch excellence to share best practices globally

Investigation and operationalization of in-licensing partnerships

Functional Strategy Evolution - Oncology Diagnostics Organization’s Operating Strategy

ValueDo supported the Head of US Oncology Diagnostics at a top 5 US pharmaceutical organization to design and implement a clear field operations strategy to improve the value of Oncology diagnostic liaisons for ‘patient identification’, and to maximize the overall value of the Diagnostics function to Oncology organization.

Value Delivered:

Sample center archetype and 5 customer personas

Goal, strategy and tactics for each persona

Focused target list across key regions

Customer segmentation and influence mapping for all key diagnostic liaisons

Lifecycle Management (LCM) Planning And Execution

ValueDo supported the VP of Global Biologics organization at top 10 pharma to conceptualize, plan, and execute business cases for the franchise. We analyzed market drivers to discover unmet needs, market size, access, and penetration rates and conducted an in-depth competitor analysis. Utilizing the company’s skills and unique qualifications, we crafted strategies to identify new opportunities with brands and investments.

Value Delivered:

Lifecycle management framework

Designed lifecycle management strategy

Shortlisted eight brand lifecycle management choices, 3 post-brand lifecycle management ideas and business cases


Maximize Value On Drug Launches - US Neurosciences Launch And Launch Excellence

ValueDo supported a top 5 US pharma Neurosciences franchise with end-to-end launch planning and management support for one of their key brand launches.

The engagement started with a launch diagnostic, progressed to brand insight and strategy refinement, and was followed by co-creation and implementation against an 18-month cross-functional launch and operational planning.

This was accomplished by a cadence of long-range planning sessions, workshops, deep-dives, 1-1s and launch tracking with US-Global and cross-functional teams.

Pivotal was day 0 execution on milestones, communications and asset deliveries across all functions.

Post-launch operational planning support was provided to maintain launch momentum. Seen as a successful launch by the management, we also assisted with a launch excellence exercise with other regions.

Value Delivered:

Quality, timely launch with well-managed FDA and internal milestones, risks and dependencies

Insights-led decision making

US and Global leadership commitment and trust

Well managed cross-functional transparency and alignment

Streamline Patient Engagement Across Market Shaping Initiatives

ValueDo supported Respiratory Market Development organization at a top 5 US pharma to streamline their patient engagement approach across the entire franchise.

Different teams within the therapy area used to reach out to patients through multiple campaigns, initiatives and assets. This led to fragmented patient engagement. ValueDo supported this transformation via a 3 phase initiative – discovery, design of a minimal viable product (MVP), and implementation.

Value Delivered:

One-Patient engagement concept with new patient-centric strategic themes

Efficiencies at local-affiliate level

New culture of synergized ways-of-working across franchise

Improved conversion across customer adoption stages


Omnichannel HCP Medical And Marketing Transformation

ValueDo supported franchise heads and their marketing leaders to scale and implement a global omnichannel medical and marketing methodology for 3 of their biologics brands across 15+ countries and all business regions. This included omnichannel subject-matter expertise, agile coaching, lean program and change management support, and implementation of a robust omnichannel methodology.

Value Delivered:

Robust global governance and methodology with localized rollout for every country

Clear content and channel strategy with improved tagging-taxonomy

Simplified measurement and reporting

Continuous improvement of field-facing adoption of omnichannel

Omnichannel success stories

Alternate Commercial Model To Improve Brand Coverage And Reach

ValueDo supported a marketing leader at top 10 pharma to conceptualize, design, and implement an alternate healthcare provider engagement model to generate new patient starts for a complex IV product. We aligned with key marketing, ops-support, and sales stakeholders to align branding and messaging, provided additional brand awareness to company offices, and provided onboarding and training for the selected telemarketing partner.

Value Delivered:

Comprehensive peer-to-peer selling model

Phase 1: 620 whitespace offices “not aware of brand” made aware, 16 new patient starts

Phase 2: Integration with patient support services, nurse education function, and sampling support organization.

Expansion of program into rep-covered territories to complement non-target list HCPs